Body markers in people at risk of inherited prion disease
Seeks body markers in people facing inherited prion disease risk.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Charlestown, United StatesSee the site
- Trial code
- Registry title
- OBSERVE: Biomarkers in Individuals at Risk for Prion Disease
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Dec 2017
- Expected to end
- 1 Jun 2027
- Type of study
- Observational
- Record updated
- 13 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults at risk of inherited prion disease, and family members without the gene change, to study blood and spinal fluid markers.
- Age
- 18 to 85 years
- Sex
- All sexes
- Disease stage
- People with no symptoms or early prion disease. Family members without the gene change and control volunteers can also join.
- Biomarker or test result
- One way in is carrying a disease-causing PRNP mutation. Others are a parent and other relatives with probable or definite prion disease, or being a non-carrier relative or control.
Main reasons for not taking part
- Other brain or nerve diseases, such as stroke, brain tumor, multiple sclerosis, Alzheimer's or Parkinson's disease
- Alcohol or drug abuse or dependence in the past two years
- Serious or unstable illness, or pregnancy, that could be a safety risk
- Blood clotting problems or blood thinners such as Coumadin that make blood draws or lumbar puncture risky
- Not fluent in English, or less than 5 years of education
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Aged 18 - 85,
- One of the following:; a. Known carrier of pathogenic PRNP mutation; b. History of probable or definite prion disease in biological parent and other family members; c. Non-carrier family members and/or unrelated previously enrolled negative control volunteers
- Medically safe to undergo blood draw, lumbar puncture and cognitive testing,
- Adequate visual and auditory acuity to complete cognitive testing,
- Fluent in English,
- At least 5 years of education,
- Capable of providing informed consent and following study procedures,
Who cannot take part
- Any CNS disease other than asymptomatic or early prion disease, such as clinical stroke, brain tumor, multiple sclerosis, significant head trauma with persistent neurological or neurocognitive deficits, Alzheimer's disease, Parkinson's disease, frontotemporal lobar degeneration or other known neurodegenerative disease,
- History of alcohol or other substance abuse or dependence within the past two years,
- Any significant systemic illness or unstable medical condition or pregnancy that could represent safety risk or affect participation in the study,
- Coagulopathy or anti-coagulant therapy (such as Coumadin) increasing the risk for phlebotomy or lumbar puncture resulting in PT/PTT and INR within 1.5 standard deviation over the upper normal limit
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Where in United States
- Alzheimer's Clinical and Translational Research UnitCharlestown, United StatesContact: Sophia D'AlessandroTaking people
About the trial
What the trial wants to find out
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
The group in the trial
- Individuals with a family history of Prion disease
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- OBSERVE: Biomarkers in Individuals at Risk for Prion Disease
- Plain-language title
- Body markers in people at risk of inherited prion diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05124392, who can take part
- Record updated
- 13 August 2026